Mood/Mobility/Women

SAM-e

Naturally occurring compound studied for depression and joint pain, used by adults seeking alternative support for mood and mobility.

SAM-e

SAM-e

58
score
B
evidence
Caution
risk

Proven Benefits

01Improves depressive symptoms
02Improves osteoarthritis pain/functi
03May reduce fibromyalgia symptoms
04May support liver function in chole

Chemical Forms

Recommended
  • SAM-e tosylate
  • SAM-e disulfate tosylate
  • Enteric-coated SAM-e
Avoid
  • Non-enteric-coated tablets (degrades rapidly in stomach acid)
  • Unstable powder forms (poor bioavailability)
Expert Note

SAM-e is highly unstable in stomach acid and moisture. Enteric-coated tablets with a stable salt form (tosylate or butanedisulfonate) protect the compound until it reaches the intestine, where absorption occurs. Non-coated forms degrade significantly before absorption, rendering them ineffective.

Protocol

Amount
400-1600 mg
Frequency
Once or twice daily
When
Morning and early afternoon on an empty stomach; avoid late-day doses to prevent insomnia.

Condition-Based Dosing

Depression, mild-to-moderate
800-1600 mg daily in divided doses for 6-8 weeks.
Osteoarthritis
600-1200 mg daily for 4-8 weeks.
Intrahepatic cholestasis of pregnancy
800 mg daily under obstetric supervision.

Safety & Limits

Upper Safe Limit
1600 mg/day (highest studied in depression trials without serious adverse effects; no official UL established)
Cycling
Safe for continuous use

Contraindications

Bipolar disorder or history of mania — may trigger hypomanic or manic episodes
Pregnancy outside of supervised cholestasis treatment — insufficient general safety data

Synergies

Methylfolate is a precursor to SAM-e via the methylation cycle; combined use may support methylation capacity in individuals with MTHFR variants.

B12 is required for methionine synthase, which regenerates methionine for SAM-e synthesis; deficiency may blunt methylation support.

Avoid Combining With

  • Serotonergic antidepressants and MAOIs (risk of serotonin syndrome — medical supervision required)
Updated Invalid Date